Key result
GPVI-targeted antithrombotic strategies demonstrate safety without bleeding complications in healthy volunteers.
Why the study?
The comparative effectiveness of different GPVI-targeted antithrombotic strategies in real-life thrombotic settings remains unknown and requires further clinical investigation.
Comparison
Different GPVI-targeted antithrombotic strategies
Design
Review
Authors
Loading...
GPVI safety data in volunteers should not yet change antithrombotic practice; leaves open efficacy and net benefit in patients.
GPVI-targeted antithrombotic strategies show a promising safety profile, warranting further clinical investigation for thromboembolic disorders.
Denorme et al. (2019) studied this question. GPVI-targeted antithrombotic strategies demonstrate a safe profile in healthy volunteers without bleeding complications, supporting their further development for thromboembolic disorders.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: